# Huzefa Bahrain

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/huzefa-bahrain/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,019 |
| Field | Hemoglobinopathies and Related Disorders |
| h-index | 9 |
| i10-index | 9 |
| OpenAlex ID | https://openalex.org/A5041483650 |
| Works | 21 |

## Researcher papers

- [Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial](https://scholariq.org/papers/intravenous-iron-optimizes-the-response-to-recombinant-human-erythropoietin-in/)
- [The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia](https://scholariq.org/papers/the-prevalence-and-impact-of-restless-legs-syndrome-on-patients-with-iron/)
- [Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia](https://scholariq.org/papers/safety-and-efficacy-of-rapidly-administered-one-hour-one-gram-of-low-molecular/)
- [Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min](https://scholariq.org/papers/safety-and-efficacy-of-total-dose-infusion-of-1-020-mg-of-ferumoxytol/)
- [Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy](https://scholariq.org/papers/safety-and-efficacy-of-rapid-1-000-mg-in-1-hr-intravenous-iron-dextran-for/)
- [Results of the First American Prospective Study of Intravenous Iron in Oral Iron-Intolerant Iron-Deficient Gravidas](https://scholariq.org/papers/results-of-the-first-american-prospective-study-of-intravenous-iron-in-oral-iron/)
- [Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy](https://scholariq.org/papers/ferumoxytol-for-the-treatment-of-iron-deficiency-and-iron-deficiency-anemia-of/)
- [Rituximab-Induced Severe Acute Thrombocytopenia: A case Report and Review of Literature](https://scholariq.org/papers/rituximab-induced-severe-acute-thrombocytopenia-a-case-report-and-review-of/)
- [A randomized double‐blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia](https://scholariq.org/papers/a-randomized-double-blind-pilot-study-to-evaluate-the-efficacy-safety-and/)
- [Rituximab Maintenance Therapy Until Progression After Rituximab and Chemotherapy Induction in Patients With Follicular Lymphoma](https://scholariq.org/papers/rituximab-maintenance-therapy-until-progression-after-rituximab-and-chemotherapy/)

## Researcher topics

- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.